key: cord-0851519-tmgj692r
authors: Galeazzi, Gian Luca; Loffi, Marco; Di Tano, Giuseppe; Danzi, Gian Battista
title: Severe COVID-19 Pneumonia and Very Late Stent Thrombosis: a Trigger or Innocent Bystander?
date: 2020-05-18
journal: Korean Circ J
DOI: 10.4070/kcj.2020.0166
sha: 28aced9876c895003c06653b7ddc52221332d9fc
doc_id: 851519
cord_uid: tmgj692r

nan

lesion of the proximal right coronary artery, that was immediately treated (Figure 1B) . A severe bilateral pneumonia was documented at chest X-ray and confirmed at computed tomography ( Figure 1C and D) . Nasopharyngeal swab tested positive for coronavirus disease 2019 (COVID-19) infection. Arterial blood gas analysis on oxygen therapy showed severe hypoxemia with a PaO 2 /FiO 2 ratio of 100. The patient was treated with noninvasive ventilation but died a few hours later of severe acute respiratory distress syndrome.

Patients with chronic coronary artery disease have an increased probability of developing an acute coronary syndrome (ACS) during acute infections. 1) COVID-19 may affect the cardiovascular system in multiple ways and these mechanisms can interact each other: direct myocardial involvement mediated via angiotensin-converting enzyme 2 2) ; hypoxemia due to severe COVID-19 infection 3) ; cytokines storm and high concentrations of inflammatory mediators that could lead to atherosclerotic plaque instability and rupture 4) ; repeated floods of catecholamines due to anxiety. 5) This case of diffuse COVID-19 pneumonia seems to confirm the role of severe infection as a precipitating factor for ACS in patients with chronic coronary artery disease, and causal relationship.

Risk of myocardial infarction and stroke after acute infection or vaccination

SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS

COVID-19 and the cardiovascular system

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Role of psychotropic medications in the treatment of adults with